Clinical Trials

COVAXIN® Only COVID-19 Vaccine To Have Demonstrated Efficacy Data From Phase III Clinical Trials Against Delta Variant At 65.2%

Bharat Biotech, a global leader in vaccine development and innovation, announced today that the safety and efficacy analysis data from…